Study Name: ATOPIC DERMATITIS
Clinics: Barnsley, Cannock, Manchester and Teesside
Therapy Area: Eczema
Gender and Age: Male and female aged 18 to 60
MAC Clinical Research is currently conducting a clinical trial to test an investigational drug for eczema, also known as atopic dermatitis.
Eczema is one of the most common types of skin diseases and affects about 10% of adults. Common features of this inflammatory skin disease include itching and dryness. Eczema often relapses, meaning symptoms will improve for a while but then return.
The purpose of this trial is to test how well the trial medication works at improving eczema, and to see how safe and well tolerated it is. During the trial, eligible participants will receive the trial medication or placebo (dummy medication). There will be approximately 12 visits to one of our clinics over a 12-month period.
Reimbursement: Up to £1350 plus reasonable travel expenses
Key Inclusion Criteria:
Male or female aged 18 to 60
Diagnosis of eczema for at least the past 6 months
BMI 18 – 35 kg/m2
Other eligibility criteria will apply. Please contact MAC for more information.
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.